nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP3A4—Temozolomide—brain cancer	0.109	0.366	CbGbCtD
Orphenadrine—CYP3A4—Lomustine—brain cancer	0.0925	0.311	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—brain cancer	0.0737	0.248	CbGbCtD
Orphenadrine—GRIN1—telencephalic ventricle—brain cancer	0.0346	0.0768	CbGeAlD
Orphenadrine—CYP3A4—Etoposide—brain cancer	0.0223	0.0752	CbGbCtD
Orphenadrine—GRIN1—ganglion—brain cancer	0.0215	0.0478	CbGeAlD
Orphenadrine—HRH1—nose—brain cancer	0.0203	0.0451	CbGeAlD
Orphenadrine—GRIN2D—hindbrain—brain cancer	0.0183	0.0407	CbGeAlD
Orphenadrine—Gastric irritation—Hydroxyurea—brain cancer	0.0168	0.0916	CcSEcCtD
Orphenadrine—GRIN1—hindbrain—brain cancer	0.0163	0.0363	CbGeAlD
Orphenadrine—SCN10A—ganglion—brain cancer	0.0128	0.0285	CbGeAlD
Orphenadrine—Epigastric discomfort—Hydroxyurea—brain cancer	0.0124	0.0675	CcSEcCtD
Orphenadrine—SCN1A—hindbrain—brain cancer	0.011	0.0244	CbGeAlD
Orphenadrine—GRIN2D—brainstem—brain cancer	0.0105	0.0233	CbGeAlD
Orphenadrine—GRIN1—brainstem—brain cancer	0.00936	0.0208	CbGeAlD
Orphenadrine—GRIN2D—telencephalon—brain cancer	0.00932	0.0207	CbGeAlD
Orphenadrine—GRIN3A—telencephalon—brain cancer	0.00876	0.0195	CbGeAlD
Orphenadrine—GRIN1—telencephalon—brain cancer	0.0083	0.0184	CbGeAlD
Orphenadrine—SLC6A2—ganglion—brain cancer	0.00799	0.0177	CbGeAlD
Orphenadrine—GRIN2D—medulla oblongata—brain cancer	0.00732	0.0163	CbGeAlD
Orphenadrine—GRIN2D—spinal cord—brain cancer	0.00653	0.0145	CbGeAlD
Orphenadrine—SCN1A—brainstem—brain cancer	0.0063	0.014	CbGeAlD
Orphenadrine—GRIN1—midbrain—brain cancer	0.00596	0.0132	CbGeAlD
Orphenadrine—GRIN1—spinal cord—brain cancer	0.00582	0.0129	CbGeAlD
Orphenadrine—GRIN2D—head—brain cancer	0.0058	0.0129	CbGeAlD
Orphenadrine—SCN1A—telencephalon—brain cancer	0.00559	0.0124	CbGeAlD
Orphenadrine—GRIN3A—head—brain cancer	0.00545	0.0121	CbGeAlD
Orphenadrine—SCN9A—pituitary gland—brain cancer	0.00529	0.0118	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—brain cancer	0.00529	0.0118	CbGeAlD
Orphenadrine—GRIN1—endocrine gland—brain cancer	0.00524	0.0116	CbGeAlD
Orphenadrine—GRIN2D—cerebellum—brain cancer	0.00517	0.0115	CbGeAlD
Orphenadrine—GRIN1—head—brain cancer	0.00517	0.0115	CbGeAlD
Orphenadrine—GRIN3A—central nervous system—brain cancer	0.00498	0.0111	CbGeAlD
Orphenadrine—SCN10A—telencephalon—brain cancer	0.00495	0.011	CbGeAlD
Orphenadrine—Aplastic anaemia—Temozolomide—brain cancer	0.00478	0.026	CcSEcCtD
Orphenadrine—SCN4A—pituitary gland—brain cancer	0.00472	0.0105	CbGeAlD
Orphenadrine—GRIN1—central nervous system—brain cancer	0.00472	0.0105	CbGeAlD
Orphenadrine—Drowsiness—Procarbazine—brain cancer	0.00471	0.0257	CcSEcCtD
Orphenadrine—SCN9A—midbrain—brain cancer	0.00467	0.0104	CbGeAlD
Orphenadrine—GRIN1—cerebellum—brain cancer	0.00461	0.0102	CbGeAlD
Orphenadrine—SCN9A—spinal cord—brain cancer	0.00456	0.0101	CbGeAlD
Orphenadrine—SCN1A—medulla oblongata—brain cancer	0.0044	0.00977	CbGeAlD
Orphenadrine—Hallucination—Procarbazine—brain cancer	0.0042	0.0229	CcSEcCtD
Orphenadrine—GRIN2D—brain—brain cancer	0.0042	0.00934	CbGeAlD
Orphenadrine—SCN10A—pituitary gland—brain cancer	0.00403	0.00896	CbGeAlD
Orphenadrine—SCN1A—midbrain—brain cancer	0.00402	0.00893	CbGeAlD
Orphenadrine—GRIN3A—brain—brain cancer	0.00395	0.00878	CbGeAlD
Orphenadrine—SCN1A—spinal cord—brain cancer	0.00392	0.00871	CbGeAlD
Orphenadrine—CHRM2—telencephalon—brain cancer	0.00383	0.00851	CbGeAlD
Orphenadrine—GRIN1—brain—brain cancer	0.00375	0.00832	CbGeAlD
Orphenadrine—Drowsiness—Hydroxyurea—brain cancer	0.00364	0.0199	CcSEcCtD
Orphenadrine—SCN4A—head—brain cancer	0.00361	0.00803	CbGeAlD
Orphenadrine—Tension—Procarbazine—brain cancer	0.00361	0.0197	CcSEcCtD
Orphenadrine—SCN1A—head—brain cancer	0.00348	0.00774	CbGeAlD
Orphenadrine—SLC6A2—brainstem—brain cancer	0.00347	0.00771	CbGeAlD
Orphenadrine—SCN10A—spinal cord—brain cancer	0.00347	0.00771	CbGeAlD
Orphenadrine—Tremor—Procarbazine—brain cancer	0.00345	0.0188	CcSEcCtD
Orphenadrine—SCN4A—central nervous system—brain cancer	0.0033	0.00733	CbGeAlD
Orphenadrine—Hallucination—Hydroxyurea—brain cancer	0.00325	0.0177	CcSEcCtD
Orphenadrine—SCN1A—central nervous system—brain cancer	0.00318	0.00706	CbGeAlD
Orphenadrine—SCN10A—endocrine gland—brain cancer	0.00312	0.00694	CbGeAlD
Orphenadrine—SCN1A—cerebellum—brain cancer	0.00311	0.0069	CbGeAlD
Orphenadrine—SCN10A—head—brain cancer	0.00308	0.00685	CbGeAlD
Orphenadrine—SLC6A2—telencephalon—brain cancer	0.00308	0.00685	CbGeAlD
Orphenadrine—Confusional state—Procarbazine—brain cancer	0.00303	0.0165	CcSEcCtD
Orphenadrine—Vomiting—Lomustine—brain cancer	0.00301	0.0164	CcSEcCtD
Orphenadrine—SCN9A—brain—brain cancer	0.00293	0.00652	CbGeAlD
Orphenadrine—Tachycardia—Procarbazine—brain cancer	0.00293	0.016	CcSEcCtD
Orphenadrine—SCN10A—central nervous system—brain cancer	0.00281	0.00625	CbGeAlD
Orphenadrine—Nausea—Lomustine—brain cancer	0.00281	0.0153	CcSEcCtD
Orphenadrine—SCN5A—head—brain cancer	0.0028	0.00622	CbGeAlD
Orphenadrine—KCNH2—telencephalon—brain cancer	0.00277	0.00615	CbGeAlD
Orphenadrine—Somnolence—Procarbazine—brain cancer	0.00267	0.0145	CcSEcCtD
Orphenadrine—Hallucination—Carmustine—brain cancer	0.00263	0.0143	CcSEcCtD
Orphenadrine—SCN4A—brain—brain cancer	0.00262	0.00582	CbGeAlD
Orphenadrine—SLC6A2—gonad—brain cancer	0.00257	0.00571	CbGeAlD
Orphenadrine—Constipation—Procarbazine—brain cancer	0.00257	0.014	CcSEcCtD
Orphenadrine—SCN5A—central nervous system—brain cancer	0.00256	0.00568	CbGeAlD
Orphenadrine—Hallucination—Temozolomide—brain cancer	0.00254	0.0139	CcSEcCtD
Orphenadrine—SCN1A—brain—brain cancer	0.00252	0.00561	CbGeAlD
Orphenadrine—Feeling abnormal—Procarbazine—brain cancer	0.00247	0.0135	CcSEcCtD
Orphenadrine—SLC6A2—medulla oblongata—brain cancer	0.00242	0.00538	CbGeAlD
Orphenadrine—CHRM2—endocrine gland—brain cancer	0.00242	0.00537	CbGeAlD
Orphenadrine—CHRM2—head—brain cancer	0.00239	0.0053	CbGeAlD
Orphenadrine—Urticaria—Procarbazine—brain cancer	0.00238	0.013	CcSEcCtD
Orphenadrine—Skin disorder—Hydroxyurea—brain cancer	0.00226	0.0123	CcSEcCtD
Orphenadrine—KCNH2—pituitary gland—brain cancer	0.00225	0.005	CbGeAlD
Orphenadrine—SCN10A—brain—brain cancer	0.00223	0.00496	CbGeAlD
Orphenadrine—HRH1—telencephalon—brain cancer	0.00222	0.00493	CbGeAlD
Orphenadrine—Hypersensitivity—Procarbazine—brain cancer	0.00221	0.0121	CcSEcCtD
Orphenadrine—Cyclizine—CYP2C9—brain cancer	0.00218	0.083	CrCbGaD
Orphenadrine—CHRM2—central nervous system—brain cancer	0.00218	0.00484	CbGeAlD
Orphenadrine—KCNH2—medulla oblongata—brain cancer	0.00217	0.00483	CbGeAlD
Orphenadrine—Vision blurred—Carmustine—brain cancer	0.00217	0.0118	CcSEcCtD
Orphenadrine—Tolterodine—CYP2C9—brain cancer	0.00216	0.0822	CrCbGaD
Orphenadrine—Tremor—Carmustine—brain cancer	0.00216	0.0118	CcSEcCtD
Orphenadrine—Asthenia—Procarbazine—brain cancer	0.00215	0.0117	CcSEcCtD
Orphenadrine—CYP2E1—telencephalon—brain cancer	0.00213	0.00473	CbGeAlD
Orphenadrine—Pruritus—Procarbazine—brain cancer	0.00212	0.0116	CcSEcCtD
Orphenadrine—Phenprocoumon—CYP2C9—brain cancer	0.00212	0.0806	CrCbGaD
Orphenadrine—Agitation—Carmustine—brain cancer	0.00211	0.0115	CcSEcCtD
Orphenadrine—Vision blurred—Temozolomide—brain cancer	0.0021	0.0114	CcSEcCtD
Orphenadrine—Tremor—Temozolomide—brain cancer	0.00208	0.0114	CcSEcCtD
Orphenadrine—Somnolence—Hydroxyurea—brain cancer	0.00207	0.0113	CcSEcCtD
Orphenadrine—Fluoxetine—CYP2C9—brain cancer	0.00206	0.0784	CrCbGaD
Orphenadrine—Agitation—Temozolomide—brain cancer	0.00204	0.0111	CcSEcCtD
Orphenadrine—SCN5A—brain—brain cancer	0.00203	0.00451	CbGeAlD
Orphenadrine—KCNH2—midbrain—brain cancer	0.00199	0.00441	CbGeAlD
Orphenadrine—Constipation—Hydroxyurea—brain cancer	0.00199	0.0108	CcSEcCtD
Orphenadrine—Dizziness—Procarbazine—brain cancer	0.00198	0.0108	CcSEcCtD
Orphenadrine—Palpitations—Temozolomide—brain cancer	0.00196	0.0107	CcSEcCtD
Orphenadrine—SLC6A2—endocrine gland—brain cancer	0.00194	0.00432	CbGeAlD
Orphenadrine—KCNH2—spinal cord—brain cancer	0.00194	0.00431	CbGeAlD
Orphenadrine—SLC6A2—head—brain cancer	0.00192	0.00426	CbGeAlD
Orphenadrine—Feeling abnormal—Hydroxyurea—brain cancer	0.00191	0.0104	CcSEcCtD
Orphenadrine—Vomiting—Procarbazine—brain cancer	0.00191	0.0104	CcSEcCtD
Orphenadrine—CYP2B6—gonad—brain cancer	0.00189	0.00421	CbGeAlD
Orphenadrine—Confusional state—Carmustine—brain cancer	0.00189	0.0103	CcSEcCtD
Orphenadrine—Warfarin—CYP2C9—brain cancer	0.00188	0.0715	CrCbGaD
Orphenadrine—Headache—Procarbazine—brain cancer	0.00188	0.0103	CcSEcCtD
Orphenadrine—Carbinoxamine—CYP2C9—brain cancer	0.00185	0.0705	CrCbGaD
Orphenadrine—Tachycardia—Carmustine—brain cancer	0.00183	0.00999	CcSEcCtD
Orphenadrine—Confusional state—Temozolomide—brain cancer	0.00183	0.00998	CcSEcCtD
Orphenadrine—Anaphylactic shock—Temozolomide—brain cancer	0.00181	0.00989	CcSEcCtD
Orphenadrine—Nausea—Procarbazine—brain cancer	0.00178	0.00972	CcSEcCtD
Orphenadrine—Skin disorder—Temozolomide—brain cancer	0.00176	0.00961	CcSEcCtD
Orphenadrine—SLC6A2—central nervous system—brain cancer	0.00175	0.00389	CbGeAlD
Orphenadrine—KCNH2—endocrine gland—brain cancer	0.00175	0.00388	CbGeAlD
Orphenadrine—CHRM2—brain—brain cancer	0.00173	0.00384	CbGeAlD
Orphenadrine—KCNH2—head—brain cancer	0.00172	0.00383	CbGeAlD
Orphenadrine—Hypersensitivity—Hydroxyurea—brain cancer	0.00171	0.00933	CcSEcCtD
Orphenadrine—CYP2E1—medulla oblongata—brain cancer	0.00167	0.00372	CbGeAlD
Orphenadrine—Somnolence—Carmustine—brain cancer	0.00167	0.0091	CcSEcCtD
Orphenadrine—Asthenia—Hydroxyurea—brain cancer	0.00167	0.00909	CcSEcCtD
Orphenadrine—Somnolence—Temozolomide—brain cancer	0.00161	0.0088	CcSEcCtD
Orphenadrine—Brompheniramine—CYP2C9—brain cancer	0.00161	0.0611	CrCbGaD
Orphenadrine—Constipation—Carmustine—brain cancer	0.00161	0.00876	CcSEcCtD
Orphenadrine—KCNH2—central nervous system—brain cancer	0.00157	0.00349	CbGeAlD
Orphenadrine—Constipation—Temozolomide—brain cancer	0.00155	0.00846	CcSEcCtD
Orphenadrine—Feeling abnormal—Carmustine—brain cancer	0.00155	0.00844	CcSEcCtD
Orphenadrine—Modafinil—CYP2C9—brain cancer	0.00154	0.0585	CrCbGaD
Orphenadrine—KCNH2—cerebellum—brain cancer	0.00154	0.00341	CbGeAlD
Orphenadrine—Dizziness—Hydroxyurea—brain cancer	0.00154	0.00838	CcSEcCtD
Orphenadrine—Dextropropoxyphene—CYP2C9—brain cancer	0.00152	0.0579	CrCbGaD
Orphenadrine—Feeling abnormal—Temozolomide—brain cancer	0.0015	0.00815	CcSEcCtD
Orphenadrine—CYP2E1—spinal cord—brain cancer	0.00149	0.00332	CbGeAlD
Orphenadrine—Vomiting—Hydroxyurea—brain cancer	0.00148	0.00805	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—brain cancer	0.00146	0.00798	CcSEcCtD
Orphenadrine—Headache—Hydroxyurea—brain cancer	0.00146	0.00793	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—brain cancer	0.00145	0.00792	CcSEcCtD
Orphenadrine—Urticaria—Temozolomide—brain cancer	0.00144	0.00786	CcSEcCtD
Orphenadrine—CYP2B6—endocrine gland—brain cancer	0.00143	0.00318	CbGeAlD
Orphenadrine—Tachycardia—Etoposide—brain cancer	0.00142	0.00773	CcSEcCtD
Orphenadrine—CYP2B6—head—brain cancer	0.00141	0.00314	CbGeAlD
Orphenadrine—Skin disorder—Etoposide—brain cancer	0.00141	0.00769	CcSEcCtD
Orphenadrine—HRH1—endocrine gland—brain cancer	0.0014	0.00311	CbGeAlD
Orphenadrine—SLC6A2—brain—brain cancer	0.00139	0.00309	CbGeAlD
Orphenadrine—Hypersensitivity—Carmustine—brain cancer	0.00138	0.00754	CcSEcCtD
Orphenadrine—HRH1—head—brain cancer	0.00138	0.00307	CbGeAlD
Orphenadrine—Nausea—Hydroxyurea—brain cancer	0.00138	0.00752	CcSEcCtD
Orphenadrine—Asthenia—Carmustine—brain cancer	0.00135	0.00735	CcSEcCtD
Orphenadrine—CYP2E1—endocrine gland—brain cancer	0.00134	0.00299	CbGeAlD
Orphenadrine—Hypersensitivity—Temozolomide—brain cancer	0.00134	0.00729	CcSEcCtD
Orphenadrine—Tamoxifen—ESR2—brain cancer	0.00133	0.0505	CrCbGaD
Orphenadrine—CYP2E1—head—brain cancer	0.00133	0.00295	CbGeAlD
Orphenadrine—Asthenia—Temozolomide—brain cancer	0.0013	0.0071	CcSEcCtD
Orphenadrine—Somnolence—Etoposide—brain cancer	0.00129	0.00704	CcSEcCtD
Orphenadrine—CYP2B6—central nervous system—brain cancer	0.00129	0.00287	CbGeAlD
Orphenadrine—Pruritus—Temozolomide—brain cancer	0.00128	0.007	CcSEcCtD
Orphenadrine—HRH1—central nervous system—brain cancer	0.00126	0.0028	CbGeAlD
Orphenadrine—KCNH2—brain—brain cancer	0.00125	0.00277	CbGeAlD
Orphenadrine—Dizziness—Carmustine—brain cancer	0.00124	0.00677	CcSEcCtD
Orphenadrine—Constipation—Etoposide—brain cancer	0.00124	0.00677	CcSEcCtD
Orphenadrine—CYP2E1—central nervous system—brain cancer	0.00121	0.00269	CbGeAlD
Orphenadrine—Dizziness—Temozolomide—brain cancer	0.0012	0.00654	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—brain cancer	0.0012	0.00652	CcSEcCtD
Orphenadrine—Vomiting—Carmustine—brain cancer	0.00119	0.00651	CcSEcCtD
Orphenadrine—CYP2E1—cerebellum—brain cancer	0.00118	0.00263	CbGeAlD
Orphenadrine—Headache—Carmustine—brain cancer	0.00118	0.00641	CcSEcCtD
Orphenadrine—Vomiting—Temozolomide—brain cancer	0.00115	0.00629	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—brain cancer	0.00115	0.00629	CcSEcCtD
Orphenadrine—Headache—Temozolomide—brain cancer	0.00114	0.0062	CcSEcCtD
Orphenadrine—Nausea—Carmustine—brain cancer	0.00112	0.00608	CcSEcCtD
Orphenadrine—Trimipramine—CYP2C9—brain cancer	0.00109	0.0414	CrCbGaD
Orphenadrine—CYP3A4—endocrine gland—brain cancer	0.00108	0.0024	CbGeAlD
Orphenadrine—Nausea—Temozolomide—brain cancer	0.00108	0.00588	CcSEcCtD
Orphenadrine—Diphenhydramine—CYP2C9—brain cancer	0.00107	0.0407	CrCbGaD
Orphenadrine—Hypersensitivity—Etoposide—brain cancer	0.00107	0.00583	CcSEcCtD
Orphenadrine—Promethazine—CYP2C9—brain cancer	0.00105	0.0399	CrCbGaD
Orphenadrine—Tamoxifen—CYP2C9—brain cancer	0.00104	0.0396	CrCbGaD
Orphenadrine—Asthenia—Etoposide—brain cancer	0.00104	0.00568	CcSEcCtD
Orphenadrine—Doxepin—CYP2C9—brain cancer	0.00104	0.0395	CrCbGaD
Orphenadrine—Methadone—CYP2C9—brain cancer	0.00103	0.0393	CrCbGaD
Orphenadrine—Pruritus—Etoposide—brain cancer	0.00103	0.0056	CcSEcCtD
Orphenadrine—CYP2B6—brain—brain cancer	0.00102	0.00228	CbGeAlD
Orphenadrine—HRH1—brain—brain cancer	0.001	0.00222	CbGeAlD
Orphenadrine—CYP3A4—central nervous system—brain cancer	0.000975	0.00217	CbGeAlD
Orphenadrine—CYP2E1—brain—brain cancer	0.000962	0.00214	CbGeAlD
Orphenadrine—Dizziness—Etoposide—brain cancer	0.00096	0.00524	CcSEcCtD
Orphenadrine—Vomiting—Etoposide—brain cancer	0.000923	0.00503	CcSEcCtD
Orphenadrine—Promazine—CYP2C9—brain cancer	0.000923	0.0351	CrCbGaD
Orphenadrine—Headache—Etoposide—brain cancer	0.00091	0.00496	CcSEcCtD
Orphenadrine—Nausea—Etoposide—brain cancer	0.000863	0.0047	CcSEcCtD
Orphenadrine—Amitriptyline—CYP2C9—brain cancer	0.000803	0.0305	CrCbGaD
Orphenadrine—GRIN1—Axon guidance—TRPC6—brain cancer	0.000197	0.00459	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000196	0.00457	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TRPC6—brain cancer	0.000194	0.00452	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000194	0.00451	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—HES1—brain cancer	0.00019	0.00443	CbGpPWpGaD
Orphenadrine—SCN9A—L1CAM interactions—EGFR—brain cancer	0.000185	0.00429	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—TP53—brain cancer	0.000183	0.00426	CbGpPWpGaD
Orphenadrine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00018	0.00419	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—APC—brain cancer	0.00018	0.00418	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TRPC6—brain cancer	0.000179	0.00416	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TRPC6—brain cancer	0.000172	0.00401	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TRPC6—brain cancer	0.000172	0.00401	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—TRPC6—brain cancer	0.00017	0.00395	CbGpPWpGaD
Orphenadrine—SCN4A—L1CAM interactions—EGFR—brain cancer	0.00017	0.00395	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000167	0.00389	CbGpPWpGaD
Orphenadrine—SCN10A—L1CAM interactions—EGFR—brain cancer	0.000164	0.00381	CbGpPWpGaD
Orphenadrine—SCN1A—L1CAM interactions—EGFR—brain cancer	0.000164	0.00381	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—VEGFA—brain cancer	0.000151	0.00352	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—IL2—brain cancer	0.000148	0.00345	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—CCND1—brain cancer	0.000145	0.00336	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TRPC6—brain cancer	0.000141	0.00328	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—RELA—brain cancer	0.00014	0.00327	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—PTCH2—brain cancer	0.00014	0.00326	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	0.000139	0.00323	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	0.000138	0.00321	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—PTCH2—brain cancer	0.000138	0.00321	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TP53—brain cancer	0.000131	0.00305	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00013	0.00303	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—HES1—brain cancer	0.000125	0.00291	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000123	0.00287	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	0.000123	0.00286	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	0.000123	0.00286	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—CTNNB1—brain cancer	0.000122	0.00284	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.000122	0.00284	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TRPC6—brain cancer	0.000121	0.00282	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—OR14C36—brain cancer	0.000121	0.00281	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—OR4C12—brain cancer	0.000121	0.00281	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—MYC—brain cancer	0.000116	0.0027	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—HES1—brain cancer	0.000115	0.00268	CbGpPWpGaD
Orphenadrine—SCN5A—L1CAM interactions—EGFR—brain cancer	0.000115	0.00268	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000114	0.00266	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—EGFR—brain cancer	0.000113	0.00264	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—OR4C12—brain cancer	0.000112	0.0026	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—OR14C36—brain cancer	0.000112	0.0026	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—HES1—brain cancer	0.000111	0.00258	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—HES1—brain cancer	0.000111	0.00258	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—OR14C36—brain cancer	0.00011	0.00256	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—OR4C12—brain cancer	0.00011	0.00256	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—STAT3—brain cancer	0.000106	0.00248	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	0.000105	0.00244	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000103	0.00239	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000101	0.00236	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000101	0.00235	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000101	0.00235	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—ERBB2—brain cancer	0.000101	0.00234	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	9.99e-05	0.00233	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.84e-05	0.00229	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CDK4—brain cancer	9.82e-05	0.00229	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.54e-05	0.00222	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TP53—brain cancer	9.52e-05	0.00222	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—ERBB2—brain cancer	9.24e-05	0.00215	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—HES1—brain cancer	9.08e-05	0.00211	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CDK4—brain cancer	9.03e-05	0.0021	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—ERBB2—brain cancer	8.91e-05	0.00207	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—ERBB2—brain cancer	8.91e-05	0.00207	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CDK4—brain cancer	8.7e-05	0.00203	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CDK4—brain cancer	8.7e-05	0.00203	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.66e-05	0.00202	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.4e-05	0.00195	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—HES1—brain cancer	7.8e-05	0.00182	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	7.75e-05	0.0018	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—APC—brain cancer	7.75e-05	0.0018	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VEGFA—brain cancer	7.75e-05	0.0018	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	7.72e-05	0.0018	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—ERBB2—brain cancer	7.29e-05	0.0017	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—RELA—brain cancer	7.22e-05	0.00168	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—SHH—brain cancer	7.22e-05	0.00168	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTCH2—brain cancer	7.19e-05	0.00167	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—ERBB2—brain cancer	7.18e-05	0.00167	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VEGFA—brain cancer	7.12e-05	0.00166	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CDK4—brain cancer	7.12e-05	0.00166	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—SHH—brain cancer	7.1e-05	0.00165	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTCH2—brain cancer	7.08e-05	0.00165	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—EGFR—brain cancer	6.97e-05	0.00162	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VEGFA—brain cancer	6.87e-05	0.0016	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VEGFA—brain cancer	6.87e-05	0.0016	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—PTCH1—brain cancer	6.84e-05	0.00159	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—SMO—brain cancer	6.84e-05	0.00159	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—PTCH1—brain cancer	6.73e-05	0.00157	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—SMO—brain cancer	6.73e-05	0.00157	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—RELA—brain cancer	6.64e-05	0.00155	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—ERBB2—brain cancer	6.6e-05	0.00154	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—OR14C36—brain cancer	6.59e-05	0.00153	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—OR4C12—brain cancer	6.59e-05	0.00153	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—OR4C12—brain cancer	6.49e-05	0.00151	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—OR14C36—brain cancer	6.49e-05	0.00151	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—EGFR—brain cancer	6.41e-05	0.00149	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—RELA—brain cancer	6.4e-05	0.00149	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—RELA—brain cancer	6.4e-05	0.00149	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—ERBB2—brain cancer	6.36e-05	0.00148	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—ERBB2—brain cancer	6.36e-05	0.00148	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CTNNB1—brain cancer	6.28e-05	0.00146	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—ERBB2—brain cancer	6.27e-05	0.00146	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ABR—brain cancer	6.21e-05	0.00145	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—EGFR—brain cancer	6.18e-05	0.00144	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—EGFR—brain cancer	6.18e-05	0.00144	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CDK4—brain cancer	6.12e-05	0.00142	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ABR—brain cancer	6.12e-05	0.00142	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CTNNB1—brain cancer	5.77e-05	0.00134	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ABR—brain cancer	5.64e-05	0.00131	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VEGFA—brain cancer	5.62e-05	0.00131	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DTX2—brain cancer	5.61e-05	0.0013	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CTNNB1—brain cancer	5.57e-05	0.0013	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CTNNB1—brain cancer	5.57e-05	0.0013	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ABR—brain cancer	5.55e-05	0.00129	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VEGFA—brain cancer	5.53e-05	0.00129	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DTX2—brain cancer	5.52e-05	0.00128	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—STAT3—brain cancer	5.47e-05	0.00127	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—RELA—brain cancer	5.24e-05	0.00122	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—ERBB2—brain cancer	5.2e-05	0.00121	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VEGFA—brain cancer	5.08e-05	0.00118	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.07e-05	0.00118	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—EGFR—brain cancer	5.05e-05	0.00118	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—STAT3—brain cancer	5.03e-05	0.00117	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EGFR—brain cancer	4.98e-05	0.00116	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VEGFA—brain cancer	4.9e-05	0.00114	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VEGFA—brain cancer	4.9e-05	0.00114	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—STAT3—brain cancer	4.85e-05	0.00113	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—STAT3—brain cancer	4.85e-05	0.00113	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VEGFA—brain cancer	4.83e-05	0.00112	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EGFR—brain cancer	4.57e-05	0.00106	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CTNNB1—brain cancer	4.55e-05	0.00106	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—RELA—brain cancer	4.5e-05	0.00105	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ERBB2—brain cancer	4.47e-05	0.00104	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.47e-05	0.00104	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EGFR—brain cancer	4.41e-05	0.00103	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EGFR—brain cancer	4.41e-05	0.00103	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—EGFR—brain cancer	4.34e-05	0.00101	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTCH2—brain cancer	4.25e-05	0.000989	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTCH2—brain cancer	4.18e-05	0.000973	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	4.17e-05	0.000971	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HES5—brain cancer	4.11e-05	0.000958	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HES5—brain cancer	4.05e-05	0.000942	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—brain cancer	4.01e-05	0.000933	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STRADA—brain cancer	3.99e-05	0.00093	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—STAT3—brain cancer	3.97e-05	0.000924	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	3.93e-05	0.000916	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STRADA—brain cancer	3.93e-05	0.000915	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CTNNB1—brain cancer	3.91e-05	0.000911	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2C9—brain cancer	3.87e-05	0.000901	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	3.87e-05	0.000901	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP2C9—brain cancer	3.79e-05	0.000882	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—SHH—brain cancer	3.71e-05	0.000862	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—SHH—brain cancer	3.65e-05	0.000848	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EGFR—brain cancer	3.61e-05	0.000839	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TRPC6—brain cancer	3.57e-05	0.000831	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	3.52e-05	0.000818	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTCH1—brain cancer	3.51e-05	0.000817	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—SMO—brain cancer	3.51e-05	0.000817	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—SMO—brain cancer	3.46e-05	0.000804	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	3.46e-05	0.000804	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—brain cancer	3.44e-05	0.000802	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—STAT3—brain cancer	3.41e-05	0.000794	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ABR—brain cancer	3.33e-05	0.000776	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—BSG—brain cancer	3.29e-05	0.000766	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ABR—brain cancer	3.28e-05	0.000763	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—BSG—brain cancer	3.22e-05	0.00075	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GLI2—brain cancer	3.22e-05	0.000749	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GLI2—brain cancer	3.17e-05	0.000737	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.16e-05	0.000736	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EGFR—brain cancer	3.1e-05	0.000721	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GLI1—brain cancer	3.03e-05	0.000705	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GLI1—brain cancer	2.98e-05	0.000693	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—VAV1—brain cancer	2.95e-05	0.000686	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	2.9e-05	0.000675	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SUFU—brain cancer	2.87e-05	0.000668	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—IDH1—brain cancer	2.83e-05	0.000659	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SUFU—brain cancer	2.82e-05	0.000657	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—IDH1—brain cancer	2.77e-05	0.000645	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GFAP—brain cancer	2.77e-05	0.000644	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GFAP—brain cancer	2.72e-05	0.000634	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—VAV1—brain cancer	2.68e-05	0.000623	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—VAV1—brain cancer	2.63e-05	0.000613	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HEY1—brain cancer	2.62e-05	0.000611	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HEY1—brain cancer	2.58e-05	0.000601	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DLL1—brain cancer	2.57e-05	0.000599	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DLL1—brain cancer	2.53e-05	0.000589	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ENO2—brain cancer	2.24e-05	0.000521	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ENO2—brain cancer	2.19e-05	0.00051	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SHH—brain cancer	2.19e-05	0.000509	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SHH—brain cancer	2.15e-05	0.000501	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TRPC6—brain cancer	2.11e-05	0.000491	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TRPC6—brain cancer	2.08e-05	0.000483	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SMO—brain cancer	2.07e-05	0.000483	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTCH1—brain cancer	2.07e-05	0.000483	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SMO—brain cancer	2.04e-05	0.000475	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTCH1—brain cancer	2.04e-05	0.000475	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.87e-05	0.000436	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.84e-05	0.000429	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.76e-05	0.000409	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.7e-05	0.000396	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.67e-05	0.000389	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.66e-05	0.000386	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.63e-05	0.00038	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VAV1—brain cancer	1.58e-05	0.000368	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.56e-05	0.000362	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BSG—brain cancer	1.5e-05	0.000348	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HES1—brain cancer	1.36e-05	0.000317	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HES1—brain cancer	1.34e-05	0.000311	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—brain cancer	1.32e-05	0.000307	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.3e-05	0.000302	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	0.000301	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—IDH1—brain cancer	1.29e-05	0.000299	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.27e-05	0.000297	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPP1—brain cancer	1.26e-05	0.000293	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPP1—brain cancer	1.24e-05	0.000288	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—brain cancer	1.2e-05	0.000278	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—brain cancer	1.18e-05	0.000274	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IRS2—brain cancer	1.14e-05	0.000265	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IRS2—brain cancer	1.12e-05	0.00026	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.03e-05	0.000239	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO2—brain cancer	1.02e-05	0.000237	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CG—brain cancer	1.01e-05	0.000234	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APC—brain cancer	1e-05	0.000234	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1e-05	0.000234	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APC—brain cancer	9.88e-06	0.00023	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	9.88e-06	0.00023	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—brain cancer	9.15e-06	0.000213	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—brain cancer	9e-06	0.000209	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RELA—brain cancer	7.85e-06	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—brain cancer	7.8e-06	0.000181	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RELA—brain cancer	7.72e-06	0.00018	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—brain cancer	7.67e-06	0.000179	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—brain cancer	7.07e-06	0.000164	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—brain cancer	6.95e-06	0.000162	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—brain cancer	6.89e-06	0.00016	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNB1—brain cancer	6.82e-06	0.000159	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—brain cancer	6.78e-06	0.000158	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	6.71e-06	0.000156	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—brain cancer	6e-06	0.00014	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—brain cancer	5.95e-06	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—brain cancer	5.91e-06	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—brain cancer	5.85e-06	0.000136	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—brain cancer	5.52e-06	0.000129	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—brain cancer	5.44e-06	0.000127	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—brain cancer	5.4e-06	0.000126	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—brain cancer	5.32e-06	0.000124	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CG—brain cancer	4.66e-06	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—brain cancer	4.54e-06	0.000106	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—brain cancer	4.46e-06	0.000104	CbGpPWpGaD
